High Rate of Invasive Fungal Infections Following Nonmyeloablative Allogeneic Transplantation

Hagen, Elisabeth A.; Stern, Hillary; Porter, David; Duffy, Kathleen; Foley, Karen; Luger, Selina; Schuster, Stephen J.; Stadtmauer, Edward A.; Schuster, Mindy G.
January 2003
Clinical Infectious Diseases;1/1/2003, Vol. 36 Issue 1, p9
Academic Journal
Nonmyeloablative allogeneic transplantation is an emerging therapy for hematologic and solid malignancies and potentially offers patients reduced transplant-related toxicity. Data regarding infectious complications of these protocols are limited, but early studies have demonstrated little infectious morbidity, particularly low rates of invasive fungal infections (IFIs). In the present study, 31 consecutive cases of nonmyeloablative transplantation were reviewed over a 2.5-year period, with a specific focus on infectious complications. Twenty-six patients (84%) had at least 1 significant infection during the year after transplantation, and infection-related mortality was 37%. Cytomegalovirus end-organ disease was diagnosed in 3 patients (10%). Ten patients (32%) were given the diagnosis of IFI; 7 (23%) met criteria for proven IFI. Fungal-related mortality was 80% within the group of patients with IFI and accounted for a significant portion of the overall mortality in the study. Severe graft-versus-host disease, high-dose corticosteroid use, recurrent neutropenia, and relapsed or refractory disease were factors associated with development of IFI.


Related Articles

  • Exacerbation of invasive aspergillosis by the immunosuppressive fungal metabolite, gliotoxin. Sutton, Philip; Waring, Paul; Müllbacher, Arno // Immunology & Cell Biology;Aug1996, Vol. 74 Issue 4, p318 

    Invasive aspergillosis is a significant cause of death in immunocompromised individuals. The majority of strains of the main causative agent, Aspergillus fumigatus, produce gliotoxin, a secondary metabolite with demonstrated in vitro immunosuppressive activity. Pretreatment of normally resistant...

  • Mixed mould species in laboratory cultures of respiratory specimens: how should they be reported, and what are the indications for susceptibility testing? Purcell, J.; McKenna, J.; Critten, P.; Denning, D. W.; Hassan, I. A. // Journal of Clinical Pathology;Jun2011, Vol. 64 Issue 6, p543 

    Aims To investigate how clinical microbiology laboratories should report and interpret mixed mould isolates including Aspergillus species from clinical samples and the criteria for susceptibility testing of the isolates. Methods Retrospectively collected data from our laboratory information...

  • Forty-one recent cases of invasive zygomycosis from a global clinical registry. Kanafani, Zeina A.; Klepser, Michael E. // Journal of Invasive Fungal Infections;2010, Vol. 4 Issue 2, p72 

    Fungiscope is a global case registry that collects data from patients with rare invasive fungal infections. The current report summarizes data from 41 patients with invasive zygomycosis.

  • Infections Due to Aspergillus terreus: A Multicenter Retrospective Analysis of 83 Cases. Steinbach, William J.; Benjamin Jr., Daniel K.; Kontoyiannis, Dimitrios P.; Perfect, John R.; Lutsar, Irja; Marr, Kieren A.; Lionakis, Michail S.; Torres, Harrys A.; Jafri, Hasan; Walsh, Thomas J. // Clinical Infectious Diseases;7/15/2004, Vol. 39 Issue 2, p192 

    Current in vitro and in vivo data indicate that invasive aspergillosis due to Aspergillus terreus is resistant to treatment with amphotericin B. Because little clinical data are available to guide therapy, we performed a retrospective cohort study of cases of invasive A. terreus infections from...

  • Combination Antifungal Therapy for Invasive Aspergillosis. Marr, Kieren A.; Boeckh, Michael; Carter, Rachel A.; Hyung Woo Kim; Corey, Lawrence // Clinical Infectious Diseases;9/15/2004, Vol. 39 Issue 6, p797 

    Background. Asp ergillosis therapy with amphotericin, azoles, or echinocandins is associated with substantial mortality, ranging from 30% to 80%, depending on the stage of infection and the host's underlying disease. Th results of in vitro studies and animal models suggest that combination...

  • Treatment of an Acute Mycotic Aneurysm of the Common Carotid Artery with a Covered Stent-Graft. Suk Hoon Lee; Young Kwon Cho; Jong Moo Park; Curie Chung; Hyun Suk Kim; Jeong Joo Woo // Yonsei Medical Journal;1/1/2012, Vol. 53 Issue 1, p224 

    We report herein a case successful endovascular treatment with a stent-graft of a rare case of rapidly growing mycotic aneurysm of the left common carotid artery due to acute bacterial endocarditis after eradication of the infection. Infected mycotic aneurysms of the peripheral vasculature have...

  • Inwazyjne zakażenia grzybicze. Passowicz-Muszyńska, Ewa; Jankowska, Renata; Kosacka, Monika // Medical Mycology / Mikologia;2008, Vol. 15 Issue 1, p43 

    Invasive fungal infections are an increasing complication for immunocompromised patients. They are associated with a high morbidity and mortality. Within the last five years substantial progress has been demonstrated for non-culture based diagnostics and treatment of invasive fungal infections....

  • Multicenter Clinical Evaluation of the (1→3) β-D-Glucan Assay as an Aid to Diagnosis of Fungal Infections in Humans. Ostrosky-Zeichner, Luis; Alexander, Barbara D.; Kett, Daniel H.; Vazquez, Jose; Pappas, Peter G.; Saeki, Fumihiro; Ketchum, Paul A.; Wingard, John; Schiff, Robert; Tamura, Hiroshi; Finkelman, Malcolm A.; Rex, John H. // Clinical Infectious Diseases;9/1/2005, Vol. 41 Issue 5, p654 

    Background. Measurement of (1→3)-β-D-glucan (BG) has emerged as an adjunct diagnostic strategy for invasive fungal infections (IFI). Methods. Subjects at 6 clinical sites in the United States were enrolled as either fungal infection-negative subjects (n = 170) or subjects with proven...

  • Î’ -D-Glucan as a Diagnostic Adjunct for Invasive Fungal Infections: Validation, Cutoff Development, and Performance in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndrome. Odabasi, Zekaver; Mattiuzzi, Gloria; Estey, Elihu; Kantarjian, Hagop; Saeki, Fumihiro; Ridge, Richard J.; Ketchum, Paul A.; Finkelman, Malcolm A.; Rex, John H.; Ostrosky-Zeichner, Luis // Clinical Infectious Diseases;7/15/2004, Vol. 39 Issue 2, p199 

    The Glucatell (1→3)-β-D-glucan (BG) detection assay (Associates of Cape Cod) was studied as a diagnostic adjunct for invasive fungal infections (IFIs). On the basis of findings from a preliminary study of 30 candidemic subjects and 30 healthy adults, a serum BG level of ⩾60 pg/mL...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics